Transcription of BRIEFING 797 Pharmaceutical Compounding—Sterile …
{{id}} {{{paragraph}}}
BRIEFING 797 Pharmaceutical Compounding Sterile Preparations, USP 41 page 6554 and PF 41(6) [Nov. Dec. 2015]. Based on the number and significance of public comments received in response to the revision proposal published in PF 41(6), the USP Compounding Expert Committee is proposing to revise this chapter. The current proposed chapter in PF 44(5) [Sept. Oct. 2018] is posted online at with line numbers. Submit comments using the form available at The Expert Committee seeks stakeholder feedback on the proposed revisions to the chapter, including the following major changes: 1.
include criteria for validated stability-indicating assays and testing for sterility, endotoxins, container-closure integrity, and particulate matter. The resource(s) are intended to guide correct interpretation and application of testing results. Minor editorial changes have been made to update the chapter to current . USP style. (CMP: J. Sun.)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}